1 / 14

Wp 4: Stimulating the environment for a wider economic exploitation and job creation

Wp 4: Stimulating the environment for a wider economic exploitation and job creation. Who are we?. Jean-Pierre Saintouil Director of the Technology Transfer Service at the Pasteur Institute, Paris Jonathan Weitzman Technology Transfer Officer at the Pasteur Institute, Paris

roz
Télécharger la présentation

Wp 4: Stimulating the environment for a wider economic exploitation and job creation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Wp 4: Stimulating the environment for a wider economic exploitation and job creation

  2. Who are we? • Jean-Pierre Saintouil Director of the Technology Transfer Service at the Pasteur Institute, Paris • Jonathan Weitzman Technology Transfer Officer at the Pasteur Institute, Paris • Kathleen Victoir Scientific Officer for the Pathogenomics network

  3. What are our objectives? Development of novel instruments to support public-private partnerships

  4. Organise a « web-based innovation market » • Organise and support a network of technology transfer and/or innovation agencies. • ….

  5. € INDUSTRY

  6. How will we proceed? 1. Establish a list of key-contact persons concerning Pathogenomic related technology transfer 2. Organise a first « kick-off » meeting with PathoGenomics Innovation Partners (first PIP- meeting, end of November 2005, Paris)

  7. Writing of a Strategy Paper, which will be diffused to an enlarged network and integration of feed-back. 4. Discussion with a) Industry and b) scientists (wp3), and integration of comments in Strategy Paper

  8. 5. SMEs/industry meeting on IPR and innovation issues (FEMS meeting in July 2006 Madrid?) 6. Web-market place for innovations (guidelines for input and use) (link with central resource centre wp3?) 7. Follow-up of the PIP-network

  9. « Kick-Off » meeting, Pasteur Institute, Paris • One Technology Transfer representative/country • Specificities of each technology transfer situation (country, institution, university,….) • Identify the gaps in the existing Technology Transfer chain

  10. Put them into the context of « Pathogenomics » e.g. * How did the « –omics » change the tech world and what are the specific problems? * What are the market specificities, (scientists, society)?

  11. Commercialisation and valorisation of technology (private sector) Structural support Incubators Science and technology parks Innovation relay centers Business innovation centres Entrepreneurship Promotion IPR and patenting Liaison for contract research Support to spin offs Knowledge and technology generation (laboratories at universities, research institutes)

  12. Application Communication between tto/industry IPR Maturation of the invention Communication between scientist/tto Invention

  13. needs (patients, scientists) identified Market social pressure Interest of Industry/SMEs Therapy Diagnosis Prophylactic treatment High troughput technology Testing of appropriate models

  14. Thank you

More Related